Stephen B. H. Kent is Director at ENZO BIOCHEM INC (ENZ). They have made 5 open-market trades across 1 company since 2008, most recently 2010-10-22.
CIK 0001387811
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ENZ | 9,654 | $3K |
Shares reported on the most recent Form 4, priced at the 2010-10-26 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENZ | SELL | 2010-10-22 | 2010-10-26 | $4.30 | $34K | +5.5% | +6.6% | +6.6% |
| ENZ | SELL | 2010-08-05 | 2010-08-06 | $4.47 | $11K | +5.5% | +6.6% | +6.6% |
| ENZ | SELL | 2010-06-11 | 2010-06-16 | $4.29 | $21K | +5.5% | +6.6% | +6.6% |
| ENZ | SELL | 2010-03-15 | 2010-03-29 | $6.15 | $31K | +5.5% | +6.6% | +6.6% |
| ENZ | SELL | 2008-02-05 | 2008-02-06 | $10.16 | $36K | +5.5% | +6.6% | +6.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.